Stewart, Martha, Insider Trading Case

The Martha Stewart insider trading case began with Stewart's sale of 3,928 shares of ImClone Systems stock on December 27, 2001, one day before the stock price fell dramatically following FDA rejection of the company's cancer drug application. Stewart sold her shares for $227,824, avoiding a loss of approximately $45,673 when the stock price dropped the next day.

Federal investigators alleged that Stewart received inside information from her Merrill Lynch broker, Peter Bacanovic, who had learned of ImClone CEO Sam Waksal's attempt to sell his family's shares before the FDA announcement. The Securities and Exchange Commission and Department of Justice launched investigations into potential securities violations by Stewart and other ImClone shareholders.

Stewart maintained that she had a pre-existing agreement to sell ImClone stock if it fell below $60 per share, a claim prosecutors disputed by demonstrating that no written record of such an agreement existed. The investigation revealed inconsistencies in Stewart's account of the sale and evidence of attempts to alter trading records after the fact.

In March 2004, Stewart was convicted on four counts: conspiracy, obstruction of justice, and two counts of lying to federal investigators. Notably, she was not convicted of insider trading itself, but rather of covering up the circumstances surrounding the stock sale and obstructing the investigation into her actions.

Stewart was sentenced to five months in federal prison, five months of home confinement, and two years of probation, along with a $30,000 fine. Her conviction demonstrated that high-profile individuals were not immune from securities law enforcement, though some critics argued the prosecution was overly aggressive for a relatively small financial gain.

The case significantly impacted Stewart's media empire, with her company Martha Stewart Living Omnimedia losing substantial value during the investigation and trial. However, Stewart's brand largely recovered after her release from prison, and she successfully rebuilt her business relationships and television presence.

The prosecution established important precedents for obstruction of justice charges in securities cases, showing that lying to investigators could result in more severe penalties than the underlying trading violations themselves.